Meet our
solutions

Product Portfolio

Hyaluronic Acid

Pharmaceutical grade Hyaluronic Acid (Sodium Hyaluronate)
Product Portfolio

PDRN & PN

Pharmaceutical grade DNA
Product Portfolio

Sodium DNA

Cosmetic grade DNA
Innovation Portfolio

Heparosan

Building on the success of Hyaluronic Acid, HTL Biotechnology now wishes to bring new opportunities with Heparosan.
Innovation Portfolio

Oligo HA

Ultra-low molecular weight Hyaluronic Acid

Our latest news

  • Articles October 8, 2024

    HTL Biotechnology at CPHI Milano

    As the leading global event for the pharmaceutical industry, CPHI Milan brought together key stakeholders from across the sector to foster connections and innovation.

  • Articles October 4, 2024

    1st symposium for HTL Biotechnology at MAIS congress

    As a key event for regenerative medicine and biotech innovation, the MAIS Congress in Marbella brought together leading professionals to explore the latest advancements in the field. A unique opportunity to share with the medical aesthetic community our biopolymers platform.

  • Articles October 3, 2024

    HTL Biotechnology will launch its White Paper at CPHI Milan!

    We are excited to announce that the HTL Biotechnology team will be attending CPHI Milan and on this occasion, we will be launching our White Paper to celebrate 90 years of discovery of Hyaluronic Acid!

  • Press releases October 1, 2024

    New Certification for HTL Biotechnology

    We are proud to announce that HTL Biotechnology has recently received Halal certification for two of our key products: DNA and HANa. Discover our press release.

    • Feel the difference with HTL inside

    Feel the difference with HTL inside

    We Are Worldwide

    A global company with a heart in Brittany

    HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.

    Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 400 million syringes of hyaluronic acid have been safely used since 2006.

    30 Years of expertise
    100+ clients
    30 countries of export
    400+ million syringes safely used since 2006

    A trusted partner

    As the market leader in pharmaceutical grade biopolymers for medical use, we work every day to :

    • Provide its customers with high-quality products ;
    • Ensure the health, safety and well-being of its employees ;
    • Control the environmental impact of its activities ;
    • Innovate in an ethical and responsible manner with its customers, suppliers and other partners.

    Have any
    questions ?

    Contact us